Analyst firms · Raymond James · ARDX

Raymond James ARDX price target and rating history

Ardelyx Inc. (ARDX) · Health Care

Raymond James rates Ardelyx Inc. (ARDX) Strong Buy with a $14 price target, as of its latest action on Sep 3, 2025. It has published 3 rating actions on ARDX since December 2023, including 0 upgrades and 1 downgrade.

Current rating
Strong Buy
Price target
$14
Median target, all firms
Too few
Actions on ARDX
3

Raymond James price target on ARDX

$14$13$11202420252026
Raymond James price target on ARDX, each point a stated target, December 2023 to September 2025.

Every Raymond James rating on ARDX

How other firms rate ARDX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Ladenburg ThalmannBuy$16Jun 16, 2026
Piper SandlerOverweightJan 9, 2026

Questions about Raymond James and ARDX

What is Raymond James's price target for ARDX?
Raymond James's latest stated price target for Ardelyx Inc. (ARDX) is $14, from its action on Sep 3, 2025.
What is Raymond James's rating on ARDX?
Raymond James rates ARDX Strong Buy, a bullish rating, as of Sep 3, 2025.
When did Raymond James last change its view on ARDX?
On Sep 3, 2025, Raymond James resumes coverage at Strong Buy, price target $14.

More ARDX rating histories

All Raymond James ratingsARDX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.